Physician profile
Reade Deleacy
NPI 1982045845
$328,694.21
in general payments reported to CMS, 2019-2025
25 companies · $65K in 2025
The $65K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $16K · 2021: $64K · 2022: $35K · 2023: $75K · 2024: $49K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $103K · Travel and Lodging: $77K · Food and Beverage: $6,863 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $102,796.52 |
| Travel and Lodging | $77,146.00 |
| Food and Beverage | $6,862.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $140,568.52 | 2019-2025 | Emboguard, Trufill, Embotrap |
| Stryker Corporation | $91,491.65 | 2019-2025 | Spinejack, Avaflex, Mild Device Kit |
| Imperative Care, INC | $37,533.61 | 2019-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Tracstar Large Distal Platform |
| Medtronic, INC. | $19,105.72 | 2021-2025 | Pipeline |
| Siemens Medical Solutions USA, INC. | $9,776.60 | 2019-2025 | Corpath Imaging System, Artis Icono Biplane |
| Scientia Vascular | $6,814.65 | 2022-2023 | |
| Penumbra, INC. | $4,617.37 | 2019-2025 | Indigo System |
| Hyprevention INC | $4,500.00 | 2023 | V-Strut Vertebral Implant |
| Asahi Intecc USA, INC. | $2,635.50 | 2021-2023 | Asahi Ptca Guide Wire |
| Spinal Simplicity, LLC | $1,568.85 | 2021-2022 | |
| Genesys Orthopedics Systems, L.L.C. | $1,400.90 | 2021 | |
| Microvention, INC. | $1,274.97 | 2020-2025 | Sofia 6f-131cm Str, Web Aneurysm Embolization System, Stent |
| Boston Scientific Corporation | $1,265.32 | 2021-2025 | Intracept |
| Medtronic USA, INC. | $1,208.46 | 2019-2020 | |
| Relievant Medsystems, INC. | $1,081.49 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,039.19 | 2020-2022 | |
| Si-Bone, INC. | $803.36 | 2025 | |
| Depuy Synthes Sales INC. | $707.48 | 2019-2023 | |
| Philips North America LLC | $540.70 | 2021 | |
| Depuy Synthes Products, INC. | $500.00 | 2022 | |
| Biosense Webster, INC. | $124.87 | 2020-2022 | |
| Balt USA, LLC | $92.69 | 2022 | |
| Route 92 Medical, INC. | $21.59 | 2025 | |
| Spineology INC. | $20.72 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reade Deleacy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.